ASTM E2045-22 PDF

Overview

ASTM E2045-22: Standard Practice for Detailed Clinical Observations of Test Animals provides a systematic approach for observing, recording, and assessing clinical signs in animals undergoing toxicological testing. This standard is issued by ASTM International and is applicable to acute, subchronic, or chronic toxicological studies conducted by various routes of administration, including inhalation, oral, dermal, and ocular exposure. ASTM E2045-22 supports consistency and reliability in test animal health assessments, aligning with regulatory requirements such as those mandated by the U.S. Environmental Protection Agency (EPA) and Good Laboratory Practices (GLP) outlined in 40 CFR.

Key Topics

Clinical Observation Methodology

• Outlines procedures for systematic clinical observation of laboratory animals, capturing both general and specific clinical signs across cutaneous, gastrointestinal, respiratory, neuromuscular, reproductive, and ocular systems.
• Emphasizes the importance of both distant and close-up observations, evaluating animal behavior, environment, physical condition, and physiological processes.

Data Standardization and Scoring

• Provides a comprehensive terminology, clinical signs codes, descriptive qualifiers, and a technique for severity scoring of observed clinical signs.
• Includes tables for coding clinical signs (e.g., alopecia, edema, hemorrhage), extent and severity scales, and anatomical location codes to ensure standardized data entry and reporting.

Regulatory and Protocol Alignment

• Facilitates compliance with EPA Good Laboratory Practices for Nonclinical Laboratory Studies (40 CFR 160, 792, 798), which require standard operating procedures for clinical observations.
• Reinforces that while the standard guides consistent practices, specific study protocols must detail actual procedures and recording forms to be used.

Quality Assurance

• Specifies adherence to GLP principles and quality assurance processes to ensure the reliability of data from toxicological studies.

Applications

ASTM E2045-22 is essential for organizations conducting toxicological testing on laboratory animals in the pharmaceutical, chemical, agrochemical, and biotechnological sectors. Its adoption provides several practical benefits:

• Facilitates regulatory compliance with national and international requirements for nonclinical study conduct.
• Ensures objective and consistent data collection, improving inter-study comparability and interpretation of toxicological findings.
• Supports early identification of adverse reactions, allowing for timely intervention in animal care and improved welfare.
• Enables accurate reporting and documentation for submission to regulatory agencies, audits, and scientific publications.
• Serves as a training tool for personnel in the proper recognition and description of clinical signs in test animals.

Related Standards

• EPA Good Laboratory Practice Standards (40 CFR Part 160, 792, 798) - Federal requirements for laboratory studies in the United States.
• OECD Principles of Good Laboratory Practice - International guidelines for conducting nonclinical safety testing.
• ASTM E2626 - Practice for the Evaluation of the Effect of Chemical Substances on Reproduction and Fertility in Test Animals.
• OECD Test Guidelines for Toxicity Studies - Widely recognized methodologies for chemical safety assessment.

Conclusion

Adopting ASTM E2045-22 enhances the quality, reliability, and regulatory acceptability of toxicological testing in animals. By promoting standardized clinical observation and reporting practices, this standard underpins both animal welfare and the integrity of scientific data in laboratory research settings. For professionals in toxicology and laboratory animal science, compliance with ASTM E2045-22 is vital for meeting both ethical and legal obligations in nonclinical safety assessment.